Opus Genetics's total assets for Q1 2025 were $48.17M, an increase of 30.67% from the previous quarter. IRD total liabilities were $43.09M for the fiscal quarter, a 42.99% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.